(Q26996937)

Jean Jmch de la Rosette

series ordinal

6

object named as

Jean J.M.C.H. de la Rosette

1 reference

1

Ernesto R. Cordeiro

1 reference

Stefan Thüroff

3

1 reference

Michael Marberger

series ordinal

4

1 reference

language of work or name

1 reference

November 2012

1 reference

1 reference

110

1 reference

issue

9

1 reference

page(s)

1228-42

1 reference

cites work

Global cancer statistics

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-410X.2012.11262.X

Biochemical outcome after radical prostatectomy, external beam radiation therapy, or interstitial radiation therapy for clinically localized prostate cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-410X.2012.11262.X

EAU guidelines on prostate cancer. Part 1: screening, diagnosis, and treatment of clinically localised disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-410X.2012.11262.X

Guideline for the management of clinically localized prostate cancer: 2007 update.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-410X.2012.11262.X

Prostate cancer laterality as a rationale of focal ablative therapy for the treatment of clinically localized prostate cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-410X.2012.11262.X

Pathologic basis of focal therapy for early-stage prostate cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-410X.2012.11262.X

Focal therapy for prostate cancer: pathologic basis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-410X.2012.11262.X

Appropriate candidates for hemiablative focal therapy are infrequently encountered among men selected for radical prostatectomy in contemporary cohort

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-410X.2012.11262.X

Predicting unilateral prostate cancer on routine diagnostic biopsy: sextant vs extended

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-410X.2012.11262.X

Focal cryotherapy for prostate cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-410X.2012.11262.X

Evaluating localized prostate cancer and identifying candidates for focal therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-410X.2012.11262.X

Understanding the pathological features of focality, grade and tumour volume of early-stage prostate cancer as a foundation for parenchyma-sparing prostate cancer therapies: active surveillance and focal targeted therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-410X.2012.11262.X

Focal therapy for localized prostate cancer: a critical appraisal of rationale and modalities

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-410X.2012.11262.X

Focal therapy for prostate cancer: possibilities and limitations

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-410X.2012.11262.X

Conceptual basis for focal therapy in prostate cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-410X.2012.11262.X

Energy-based ablative therapy of prostate cancer: high-intensity focused ultrasound and cryoablation

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-410X.2012.11262.X

Production of focal destructive lesions in the central nervous system with ultrasound

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-410X.2012.11262.X

Tumor irradiation with intense ultrasound

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-410X.2012.11262.X

High intensity focused ultrasound--a surgical technique for the treatment of discrete liver tumours.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-410X.2012.11262.X

Thermal model for ultrasonic treatment of glaucoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-410X.2012.11262.X

High-intensity focused ultrasound in the treatment of prostatic tissue.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-410X.2012.11262.X

High intensity focused ultrasound in benign prostatic hyperplasia

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-410X.2012.11262.X

High-intensity focused ultrasound: current potential and oncologic applications

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-410X.2012.11262.X

High intensity focused ultrasound: surgery of the future?

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-410X.2012.11262.X

High intensity focused ultrasound (HIFU) for prostate cancer: current clinical status, outcomes and future perspectives

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-410X.2012.11262.X

Cavitation and contrast: the use of bubbles in ultrasound imaging and therapy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-410X.2012.11262.X

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-410X.2012.11262.X

High-intensity focused ultrasound principles, current uses, and potential for the future

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-410X.2012.11262.X

High intensity focused ultrasound: physical principles and devices.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-410X.2012.11262.X

MRI appearance of prostate following transrectal HIFU ablation of localized cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-410X.2012.11262.X

Real-time adaptive methods for treatment of mobile organs by MRI-controlled high-intensity focused ultrasound

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-410X.2012.11262.X

Elastography for the follow-up of high-intensity focused ultrasound prostate cancer treatment: initial comparison with MRI.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-410X.2012.11262.X

Robotic high-intensity focused ultrasound for prostate cancer: what have we learned in 15 years of clinical use?

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-410X.2012.11262.X

The clinical applications of high intensity focused ultrasound in the prostate

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-410X.2012.11262.X

Transrectal high-intensity focused ultrasound devices: a critical appraisal of the available evidence

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-410X.2012.11262.X

Robot-assisted high-intensity focused ultrasound in focal therapy of prostate cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-410X.2012.11262.X

Sonablate-500: transrectal high-intensity focused ultrasound for the treatment of prostate cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-410X.2012.11262.X

Transrectal high-intensity focused ultrasound in the treatment of localized prostate cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-410X.2012.11262.X

High-intensity focused ultrasound for prostate cancer: a systematic review.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-410X.2012.11262.X

Systematic review of the efficacy and safety of high-intensity focussed ultrasound for the primary and salvage treatment of prostate cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-410X.2012.11262.X

High-intensity focused ultrasound in prostate cancer; a systematic literature review of the French Association of Urology

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-410X.2012.11262.X

High intensity focused ultrasound for prostate cancer: a review of the scientific foundation, technology and clinical outcomes

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-410X.2012.11262.X

Current status of HIFU and cryotherapy in prostate cancer--a review

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-410X.2012.11262.X

High-intensive focused ultrasound in localized prostate cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-410X.2012.11262.X

Results and side effects of high-intensity focused ultrasound in localized prostate cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-410X.2012.11262.X

High-Intensity Focused Ultrasound and Localized Prostate Cancer: Efficacy Results from the European Multicentric Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-410X.2012.11262.X

The status of high-intensity focused ultrasound in the treatment of localized prostate cancer and the impact of a combined resection.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-410X.2012.11262.X

Transrectal high-intensity focused ultrasound: minimally invasive therapy of localized prostate cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-410X.2012.11262.X

Transrectal high intensity focused ultrasound for the treatment of localized prostate cancer: factors influencing the outcome.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-410X.2012.11262.X

Control of prostate cancer by transrectal HIFU in 227 patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-410X.2012.11262.X

High-intensity focused ultrasound for the treatment of localized prostate cancer: 5-year experience

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-410X.2012.11262.X

Eight years' experience with high-intensity focused ultrasonography for treatment of localized prostate cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-410X.2012.11262.X

Morbidity associated with repeated transrectal high-intensity focused ultrasound treatment of localized prostate cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-410X.2012.11262.X

First analysis of the long-term results with transrectal HIFU in patients with localised prostate cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-410X.2012.11262.X

High-intensity focused ultrasound therapy for clinically localized prostate cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-410X.2012.11262.X

Oncologic control provided by HIFU therapy as single treatment in men with clinically localized prostate cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-410X.2012.11262.X

Transrectal high-intensity focused ultrasound (HIFU) treatment of localized prostate cancer: review of technical incidents and morbidity after 5 years of use.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-410X.2012.11262.X

Multicentric oncologic outcomes of high-intensity focused ultrasound for localized prostate cancer in 803 patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-410X.2012.11262.X

Treatment of localized prostate cancer using high-intensity focused ultrasound.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-410X.2012.11262.X

Five years experience of transrectal high-intensity focused ultrasound using the Sonablate device in the treatment of localized prostate cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-410X.2012.11262.X

The effect of neoadjuvant androgen suppression on prostate cancer-related outcomes after high-intensity focused ultrasound therapy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-410X.2012.11262.X

To what extent does the prostate-specific antigen nadir predict subsequent treatment failure after transrectal high-intensity focused ultrasound therapy for presumed localized adenocarcinoma of the prostate?

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-410X.2012.11262.X

Transrectal high-intensity focused ultrasound for the treatment of localized prostate cancer: eight-year experience.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-410X.2012.11262.X

Focal therapy with high-intensity-focused ultrasound in the treatment of localized prostate cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-410X.2012.11262.X

Efficacy of short-term androgen deprivation with high-intensity focused ultrasound in the treatment of prostate cancer in Japan.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-410X.2012.11262.X

Transurethral resection of the prostate immediately after high-intensity focused ultrasound treatment for prostate cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-410X.2012.11262.X

Visually directed transrectal high intensity focused ultrasound for the treatment of prostate cancer: a preliminary report on the Italian experience

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-410X.2012.11262.X

High-intensity-focused ultrasound in the treatment of primary prostate cancer: the first UK series

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-410X.2012.11262.X

Quality of life following high-intensity focused ultrasound for the treatment of localized prostate cancer: a prospective study

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-410X.2012.11262.X

Clinically significant urethral stricture and/or subclinical urethral stricture after high-intensity focused ultrasound correlates with disease-free survival in patients with localized prostate cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-410X.2012.11262.X

Transrectal high-intensity focused ultrasound for treatment of localized prostate cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-410X.2012.11262.X

Local recurrence of prostate cancer after external beam radiotherapy: early experience of salvage therapy using high-intensity focused ultrasonography

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-410X.2012.11262.X

Mid-term results demonstrate salvage high-intensity focused ultrasound (HIFU) as an effective and acceptably morbid salvage treatment option for locally radiorecurrent prostate cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-410X.2012.11262.X

Focal therapy for localized prostate cancer: a phase I/II trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-410X.2012.11262.X

Phase I/II trial of high intensity focused ultrasound for the treatment of previously untreated localized prostate cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-410X.2012.11262.X

New treatments for localized prostate cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-410X.2012.11262.X

[Outcomes of HIFU for localised prostate cancer using the Ablatherm Integrate Imaging® device].

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-410X.2012.11262.X

Transrectal focused ultrasound combined with transurethral resection of the prostate for the treatment of localized prostate cancer: feasibility study

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-410X.2012.11262.X

High-intensity focused ultrasound for prostate cancer: comparative definitions of biochemical failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-410X.2012.11262.X

Focal therapy in prostate cancer: future trends.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-410X.2012.11262.X

Focal therapy in prostate cancer-report from a consensus panel.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-410X.2012.11262.X

Transatlantic Consensus Group on active surveillance and focal therapy for prostate cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-410X.2012.11262.X

PSA nadir is a significant predictor of treatment failure after high-intensity focussed ultrasound (HIFU) treatment of localised prostate cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-410X.2012.11262.X

10.1111/J.1464-410X.2012.11262.X

21 January 2018

Identifiers

DOI

0 references

PubMed publication ID

22672199

1 reference